Union Jobs Report

PILMA news

PRESS RELEASE New Study Demonstrates Critical Role of American Workers in Building Life-Saving Medicine Infrastructure

June 17, 2025 Research shows the U.S. pharmaceutical industry generated 65 million labor hours and $2.6 billion in wages for skilled union workers who built and maintained advanced pharmaceutical manufacturing facilities across 18 states over the past five years. The Pharmaceutical Industry Labor-Management Association (PILMA) today released groundbreaking research demonstrating

Read More »

Statement on Executive Order

PILMA Urges Congress to Address IRA’s “Pill Penalty” Following Executive Action April 17, 2025 Bipartisan EPIC Act offers solution to protect patient access, pharmaceutical The Pharmaceutical Industry Labor-Management Association (PILMA) welcomes renewed attention to the harmful impacts of the Inflation Reduction Act’s so-called “pill penalty,” highlighted in the April 15

Read More »

PILMA Applauds Reintroduction of the Ensuring Pathways to Innovative Cures (EPIC) Act

February 25, 2025 PILMA Applauds Reintroduction of the Ensuring Pathways to Innovative Cures (EPIC) Act Bipartisan legislation would correct the “pill penalty” to safeguard union jobs and ensure continued innovation in small-molecule therapies The Pharmaceutical Industry Labor-Management Association (PILMA) applauds the introduction of the Ensuring Pathways to Innovative Cures (EPIC)

Read More »

Facility Tours

PILMA – IUOE LOCAL 150 FACILITY TOUR

Mental Health Lunch and Learn with UA Local 9

Pipefitters Local 455 Apprenticeship Tour and Industry

Labor-Industry Collaboration Highlighted at Astellas West Coast Innovation Center Tour

Eli Lilly Facility Tour

IUOE LOCAL 12 FACILITY TOUR, NEVADA

IUOE LOCAL 12 FACILITY TOUR, NEVADA

PHILADELPHIA STEAMFITTERS LOCAL 420 TRAINING CENTER 

Maryland Senator Chris Van Hollen Tours IBEW Local 26

Resolutions

Reports

Most-Favored-Nation Drug Pricing: A Threat to American Workers and Innovation

An Understanding and Implications of the Cost Drivers in the Drug Supply Chain

Impact of Medicare Part D Rebates on Multi-employer Plans

Jobs Today: Cures Tomorrow—Innovation and the Biopharmaceutical Industry

Health Care Reform for Workers and Working Families